Verily has pulled off a recruitment coup, hiring former FDA Commissioner Robert Califf as a company advisor. It comes at a crucial time as top talent leaves and criticism of CEO Andrew Conrad persists.
Also, we talk about the big health security glitch of the week: Tech issues at Hospital Corporation of America that led to the shutdown of some of its electronic health record system.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Verily, formerly known as Google Life Sciences, is aimed at melding tech and healthcare "to create a true picture of human health."
Here's an overview of how Google Ventures has invested in healthcare and the life sciences just this year.
"When you think about Google and data, people begin to wonder - is my search information going to be used as a mental health biomarker? Or to make a diagnosis? I don't think that's ever likely going to happen," Insel said.
DexCom has partnered with Google's life sciences arm to build a next-gen continuous glucose monitor. The new devices, expected out in the next 2-3 years, will be much smaller and cheaper, the companies say.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.